Oventus Medical (ASX:OVN) Treasury Stock : A$0.00 Mil (As of Dec. 2021)

View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Oventus Medical's treasury stock for the quarter that ended in Dec. 2021 was A$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Oventus Medical Treasury Stock Historical Data

The historical data trend for Oventus Medical's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical Treasury Stock Chart

Oventus Medical Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Treasury Stock

Oventus Medical Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Treasury Stock	Get a 7-Day Free Trial						-	-	-	-	-

Oventus Medical Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Oventus Medical (ASX:OVN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068

Website

https://www.o2vent.com

Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines